Extraction and Characterization of Natural Higher Aliphatic Alcohol from Sugarcane Wax

Total Page:16

File Type:pdf, Size:1020Kb

Extraction and Characterization of Natural Higher Aliphatic Alcohol from Sugarcane Wax s i n S S al E n o u A i E s g R R s R e a C A of r H r G a U P n & f S o d I P R n n t R o i e O t g F O a IAPSIT i r a M c Y o t e T O s d s E T T I A I e l C O c a h n O N RESEARCH ARTICLE T n o i o S w o t w o a l a r o r n r d o g r s e m i t a o e n S T s I w s e u e o t e r r e a nd Prosp Estd. 2004 Sugar Tech 9(4) (2007) : 244-248 Extraction and Characterization of Natural Higher Aliphatic Alcohol from Sugarcane Wax GAN-LIN CHEN1* , HAI-RONG GUO2, XIAO-FEI WANG2 and YANG-RUI LI3 1Guangxi Sugarcane Research Institute, Nanning 530007, China 2College of Light Industry and Food Engineering, Guangxi University, Nanning 530004, China 3Guangxi Academy of Agricultural Sciences, Nanning 530007, China ABSTRACT Natural higher aliphatic alcohol (HAA), a bioactive substance, is widely found in waxy materials such as sugarcane wax, and can be extracted from filter mud or bagasse in sugar mill. This material is widely used in food, medicine and cosmetics industries as a kind of natural additive. In the present study, the purified HAA and its by-product of higher fatty acids (HFA) was extracted and purified through a series of processes that involve saponification and hydrolysis with alkali, calcification, Soxhlet extraction and crystallization by gradient cooling. The process of extracting the HAA from sugarcane wax was described and optimized using an orthogonal experimental design. From the analytic identification and quantification using GC-MS, the purified HAA obtained was found to be up to 90.7% in purity. The total content of the main bioactive components containing an even number of carbon atoms from C22 to C30 can reach up to 40.5%. Key words: higher aliphatic alcohol, higher fatty acid, extraction, characterization, by-products INTRODUCTION As the properties of sugarcane wax are similar to the rare Carnauba wax (Cai, 1994), sugarcane wax will be a likely Sugarcane wax, one of the higher vegetable waxes, is a substitute for Carnauba wax in the future. Sugarcane wax also kind of lipid found in sugarcane, which contains waxy lipids has a wide range of uses and contains other natural bioactive and fatty lipids, making up about 0.18~0.26% of the weight of substances such as phytosterol, octacosanol and other higher milling cane. Waxy lipids are a kind of compact crystalline aliphatic alcohols, which can be extracted and used as natural substance that is anchored on the cuticle of the stalk and the additive for functional foods, medicine and cosmetics (Chen node of sugarcane, comprising about 0.12% of the cane weight. et al., 2005). Fatty lipids are found inside of the sugarcane stalk and are the Higher aliphatic alcohol (HAA), which is also called higher major component of vegetable cell plasma. It's content is aliphatic alkanol or long-chain fatty alcohol, is a mixture of variable depending on the variety and the growth conditions higher saturated aliphatic primary alcohols containing 22-38 of sugarcane. In the milling process of sugarcane, about 60% carbons that has been widely found in waxy materials such as of the lipids is left in the bagasse. The rest is transferred into sugarcane wax, rice bran wax, beeswax, apple peel and wheat the mixed juice, of which 95% goes to the sediment of the filter germ (Kazuko et al., 1991). Its healthy benefits and biological mud when lime milk is added during the clarification of the activity include curing or healing hypercholesterolemia, mixed juice (Cai, 1994). Therefore, sugarcane wax is usually atherosclerotic complications as platelet hyperaggregabiulity, produced by extraction from filter mud or press mud waste ischemia and thrombosis, and preventing drug induced gastric and bagasse (Phukan et al., 1999; Chen et al., 2004). Most of ulcer and improving male sexual activity (Laguna et al., 1999). the sugarcane wax product used in the experiment was obtained from filter mud. The monocomponent of aliphatic alcohol has its own respective biological activity and health benefits. For instance, *Corresponding author e-mail: [email protected] ©2007 Society for Sugar Research and Promotion Gan-Lin Chen, Hai-Rong Guo, Xiao-Fei Wang and Yang-Rui Li docosanol (C22) can be used for restraining tumor of prostate, hours and then shaken at a constant temperature of 80oC for tetracosanol (C24) for strengtherning nerve system, 24-36 hours in order to obtain the mixture of higher fatty acids hexacosanol (C26) for lowering blood fat, octacosanol (C28) salts (K-HFA) and HAA. for lowering blood lipid or cholesterol (Arruzazabala et al., Calcification 1994), improving athletic performance (Rapport, 2000; Durden et al., 1993), offering cytoprotection role of trophic nerve The HFA components were separated from the HAA by (Carbajal et al., 1996), inhibiting blood platelet aggregation adding saturated calcium chloride (CaCl2) solution, equivalent (Carbajal et al., 1998), triacontanol (C30) for regulating and to the KOH used, in order to precipitate the water-insoluble controlling plant growth (Ries et al., 1977). calcium fatty acid salt (Ca-FA). The calcification reaction was maintained for 2-3 hours at 80oC and produced a precipitate of At present, there is a large gap between the demand of granules about 1 mm in diameter, which was washed with hot- sugarcane wax and higher aliphatic alcohol and the supply of water, dried at 60-65oC and crushed. the materials in the domestic and foreign markets, especially the mixture of HAA that is rich in the octacosanol (C28) Soxhlet Refluxing Extraction (SRE) ingredient. In order to optimize the operating conditions of the Guangxi Zhuang Autonomous Region, the biggest sugar- extraction solvent, the refluxing temperature and the extraction producing province in China, produced 7.18 million tons of time, the SRE experiments were performed in nine groups using sugar in 2006/2007 milling season, accounting for over 60% of 4 an orthogonal design of L9 (3 ) and the experiment results the total sugar output in the country. The sugar industry is were evaluated using the yield and production rate of the rich in raw materials of HAA, such as the sugarcane wax that is crude HAA and the purified HAA as measures. found in the filter mud and bagasse. This study deals with the extraction of HAA from sugarcane wax in filter mud. The The mixture of HAA and Ca-FA (5.00 g) was taken to operating processes were optimized to obtain the purified HAA extract the HAA mixture for 8-16 hours by Soxhlet extraction with high purity. The analyses of purified HAA and higher (SOTEX ANANTI) and all treatments were performed in the o fatty acids (HFA) products were carried out using GC-MS to range of 50-80 C in the medium containing 6-8 times (for the identify, quantify and characterize the monocomponents. ratio of weight of solid and volume of liquid, g/mL) of organic solvent such as acetone, anhydrous ether and mineral ether. At the given reaction time, samples of extractive liquor were MATERIALS AND METHODS taken from the Soxhlet extractor and dried and weighed. The sugarcane wax was derived from the filter mud of a Purification and crystallization sugar mill (Shangsi Sugar Mill, Guangxi, China) and refined by In the present study, the crude HAA obtained in each deliming, degreasing and decolouring. It was air-dried, crushed group was purified by crystallization using solvents such as and homogenized and stored until needed. Analyses of the n-hexane, methanol and chloroform. The crude HAA was air- refined sugarcane wax were carried out using methods reported dried and then recrystallized 3-4 times with n-hexane through by Chen (2006). The main physical and chemical properties of the crystallization of gradient cooling from 75oC to room the refined sugarcane wax are shown in Table 1. temperature. Samples of purified HAA were collected and Table 1: Main physico-chemical constants of sugarcane wax weighed at certain time. used in this study Recovery of HFA Physico-chemical constants Experimental data Color Brown The residues in each extraction thimble (that is, the Melting point (oC) 74~80 mixture of calcium fatty acids (Ca-FA)) were collected and Saponification value (mg KOH/g) 80.76 weighed. Samples of the Ca-FA mixture (2.0 g) were heated to Acid value (mg KOH/g) 25.24 80oC with 4 times of water (corresponding to the weight of Ca- Esters value (mg KOH/g) 55.52 FA) and adding the quantitative concentrated HCl to adjust Iodine value (g I2/100g) 18.23 pH to 1-1.5. After being boiled for 2-3 hours, the solid granule disappeared and the solid phase was left. At the end, the Saponification crude HFA was obtained through washing the acid solid phase The saponification (hydrolysis with alkali) of the to neutral products with hot water and drying at 50-55oC. sugarcane wax converts the component esters into the Analysis of HAA and HFA respective alcohols and acids. In this work, a 10.0 g sample of the sugarcane wax was added to 30 mL of triple-distilled water Thirty mL of acetylating agent was added to a 2.0 g containing a few drops of polyglycol as a surfactant, plus 20 sample of purified HAA and refluxed for 1 hour at 75 oC. The mL of 0.2 M KOH (Chen, 2006).
Recommended publications
  • (12) United States Patent (10) Patent No.: US 9,375.433 B2 Dilly Et Al
    US009375433B2 (12) United States Patent (10) Patent No.: US 9,375.433 B2 Dilly et al. (45) Date of Patent: *Jun. 28, 2016 (54) MODULATORS OF ANDROGENSYNTHESIS (52) U.S. Cl. CPC ............. A6 IK3I/519 (2013.01); A61 K3I/201 (71) Applicant: Tangent Reprofiling Limited, London (2013.01); A61 K3I/202 (2013.01); A61 K (GB) 31/454 (2013.01); A61K 45/06 (2013.01) (72) Inventors: Suzanne Dilly, Oxfordshire (GB); (58) Field of Classification Search Gregory Stoloff, London (GB); Paul USPC .................................. 514/258,378,379, 560 Taylor, London (GB) See application file for complete search history. (73) Assignee: Tangent Reprofiling Limited, London (56) References Cited (GB) U.S. PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this 5,364,866 A * 1 1/1994 Strupczewski.......... CO7C 45/45 patent is extended or adjusted under 35 514,254.04 U.S.C. 154(b) by 0 days. 5,494.908 A * 2/1996 O’Malley ............. CO7D 261/20 514,228.2 This patent is Subject to a terminal dis 5,776,963 A * 7/1998 Strupczewski.......... CO7C 45/45 claimer. 514,217 6,977.271 B1* 12/2005 Ip ........................... A61K 31, 20 (21) Appl. No.: 14/708,052 514,560 OTHER PUBLICATIONS (22) Filed: May 8, 2015 Calabresi and Chabner (Goodman & Gilman's The Pharmacological (65) Prior Publication Data Basis of Therapeutics, 10th ed., 2001).* US 2015/O238491 A1 Aug. 27, 2015 (Cecil's Textbook of Medicine pp. 1060-1074 published 2000).* Stedman's Medical Dictionary (21st Edition, Published 2000).* Okamoto et al (Journal of Pain and Symptom Management vol.
    [Show full text]
  • WO 2017/074902 Al 4 May 20 17 (04.05.2017) W P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/074902 Al 4 May 20 17 (04.05.2017) W P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K 8/37 (2006.01) A61Q 19/00 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, A61K 31/215 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (21) International Application Number: KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, PCT/US2016/058591 MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (22) International Filing Date: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 25 October 2016 (25.10.201 6) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (25) Filing Language: English ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 62/247,803 29 October 20 15 (29. 10.20 15) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (71) Applicant: GLAXOSMITHKLINE CONSUMER TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, HEALTHCARE HOLDINGS (US) LLC [US/US]; 271 1 DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, Centerville Road, Suite 400, Wilmington, DE 19808 (US).
    [Show full text]
  • United States Patent (19) 11 Patent Number: 5,034,441 Nakano Et Al
    United States Patent (19) 11 Patent Number: 5,034,441 Nakano et al. 45 Date of Patent: Jul. 23, 1991 54 STYRENE-BASED RESIN COMPOSITION (56. References Cited AND PROCESS FOR PRODUCING U.S. PATENT DOCUMENTS MOLDING PRODUCTS THEREOF 4,463,113 7/1984 Nakahara et al. ................... 524/117 4,619,959 10/1986 Matsubara et al. .. ... 524/228 75) Inventors: Akikazu Nakano; Takashi Sumitomo, 4,680,353 7/1987 Ishihara et al. .. ... 526/59 both of Ichihara, Japan 4,820,772 4/1989 Goto et al. .......................... 524/117 73 Assignee: Idemitsu Kosan Co., Ltd., Tokyo, Primary Examiner-Joseph L. Schofer Japan Assistant Examiner-Mark D. Sweet Attorney, Agent, or Firm-Frishauf, Holtz, Goodman & (21) Appl. No.: 559,971 Woodward 57 ABSTRACT (22 Filed: Jul. 27, 1990 Disclosed is a styrene-based resin composition which comprises (a) 100 parts by weight of styrene-based poly Related U.S. Application Data mer having a high degree of syndiotactic configuration, 63 Continuation-in-part of Ser. No. 470,975, Jan. 26, 1990, (b) 0.01 to 15 parts by weight of at least one nucleating abandoned. agent selected from an organophosphorus compound and a metal salt of an organic acid, and (c) 0.01 to 15 (30) Foreign Application Priority Data parts by weight of at least one component selected from a polyoxyalkylene compound, a fatty acid and a deriva Feb. 2, 1989 (JP) Japan .................................... 1-22587 tive thereof. 51 Int. Cli................................................ C08K 5/15 The composition can produce various molding prod 52 U.S. C. .................................... 524/117; 524/127; ucts with excellent mold-releasing property, surface 524/377; 524/385; 524/388; 524/307; 524/228; gloss, bending strength, bending modulus and heat resis 524/577; 524/394 tance.
    [Show full text]
  • Biochemistry Prologue to Lipids
    Paper : 05 Metabolism of Lipids Module: 01 Prologue to Lipids Principal Investigator Dr. Sunil Kumar Khare, Professor, Department of Chemistry, IIT-Delhi Paper Coordinator and Dr. Suaib Luqman, Scientist (CSIR-CIMAP) Content Writer & Assistant Professor (AcSIR) CSIRDr. Vijaya-CIMAP, Khader Lucknow Dr. MC Varadaraj Content Reviewer Prof. Prashant Mishra, Professor, Department of Biochemical Engineering and Biotechnology, IIT-Delhi 1 METABOLISM OF LIPIDS Biochemistry Prologue to Lipids DESCRIPTION OF MODULE Subject Name Biochemistry Paper Name 05 Metabolism of Lipids Module Name/Title 01 Prologue to Lipids 2 METABOLISM OF LIPIDS Biochemistry Prologue to Lipids 1. Objectives To understand what is lipid Why they are important How they occur in nature 2. Concept Map LIPIDS Fatty Acids Glycerol 3. Description 3.1 Prologue to Lipids In 1943, the term lipid was first used by BLOOR, a German biochemist. Lipids are heterogeneous group of compounds present in plants and animal tissues related either actually or potentially to the fatty acids. They are amphipathic molecules, hydrophobic in nature originated utterly or in part by thioesters (carbanion-based condensations of fatty acids and/or polyketides etc) or by isoprene units (carbocation-based condensations of prenols, sterols, etc). Lipids have the universal property of being: i. Quite insoluble in water (polar solvent) ii. Soluble in benzene, chloroform, ether (non-polar solvent) 3 METABOLISM OF LIPIDS Biochemistry Prologue to Lipids Thus, lipids include oils, fats, waxes, steroids, vitamins (A, D, E and K) and related compounds, such as phospholipids, triglycerides, diglycerides, monoglycerides and others, which are allied more by their physical properties than by their chemical assests.
    [Show full text]
  • Fatty Acids, Trivial and Systematic Names
    FATTY ACIDS, TRIVIAL AND SYSTEMATIC NAMES Trivial Name Systematic Name Abbreviation Formic Acid Methanoic Acid Acetic Acid Ethanoic Acid Propionic Acid Propanoic Acid Butyric Acid Butanoic Acid 4:0 Valerianic Acid Pentanoic Acid 5:0 Caproic Acid Hexanoic Acid 6:0 Enanthic Acid Heptanoic Acid 7:0 Caprylic Acid Octanoic Acid 8:0 Pelargonic Acid Nonanoic Acid 9:0 Capric Acid Decanoic Acid 10:0 Obtusilic Acid 4-Decenoic Acid 10:1(n-6) Caproleic Acid 9-Decenoic Acid 10:1(n-1) Undecylic Acid Undecanoic Acid 11:0 Lauric Acid Dodecanoic Acid 12:0 Linderic Acid 4-Dodecenoic Acid 12:1(n-8) Denticetic Acid 5-Dodecenoic Acid 12:1(n-7) Lauroleic Acid 9-Dodecenoic Acid 12:1(n-3) Tridecylic Acid Tridecanoic Acid 13:0 Myristic Acid Tetradecanoic Acid 14:0 Tsuzuic Acid 4-Tetradecenoic Acid 14:1(n-10) Physeteric Acid 5-Tetradecenoic Acid 14:1(n-9) Myristoleic Acid 9-Tetradecenoic Acid 14:1(n-5) Pentadecylic Acid Pentadecanoic Acid 15:0 Palmitic Acid Hexadecanoic Acid 16:0 Gaidic acid 2-Hexadecenoic Acid 16:1(n-14) Sapienic Acid 6-Hexadecenoic Acid 16:1(n-10) Hypogeic Acid trans-7-Hexadecenoic Acid t16:1(n-9) cis-Hypogeic Acid 7-Hexadecenoic Acid 16:1(n-9) Palmitoleic Acid 9-Hexadecenoic Acid 16:1(n-7) Palmitelaidic Acid trans-9-Hexadecenoic Acid t16:1(n-7) Palmitvaccenic Acid 11-Hexadecenoic Acid 16:1(n-5) Margaric Acid Heptadecanoic Acid 17:0 Civetic Acid 8-Heptadecenoic Acid 17:1 Stearic Acid Octadecanoic Acid 18:0 Petroselinic Acid 6-Octadecenoic Acid 18:1(n-12) Oleic Acid 9-Octadecenoic Acid 18:1(n-9) Elaidic Acid trans-9-Octadecenoic acid t18:1(n-9)
    [Show full text]
  • ( 12 ) United States Patent
    US010155042B2 (12 ) United States Patent ( 10 ) Patent No. : US 10 , 155 , 042 B2 Bannister et al. (45 ) Date of Patent: * Dec. 18 , 2018 ( 54 ) COMPOSITIONS AND METHODS FOR A61K 31/ 60 (2006 . 01) TREATING CHRONIC INFLAMMATION A61K 47 / 10 ( 2017 .01 ) AND INFLAMMATORY DISEASES A61K 31 / 202 (2006 . 01 ) A61K 31 / 337 (2006 .01 ) ( 71 ) Applicant: Infirst Healthcare Limited , London A61K 31 / 704 ( 2006 . 01 ) (GB ) A61K 31/ 25 (2006 . 01) 2 ) U . S . CI. ( 72 ) Inventors : Robin M . Bannister , Essex (GB ) ; John CPC .. .. .. .. A61K 47 / 14 ( 2013 .01 ) ; A61K 9 / 08 Brew , Hertfordshire (GB ) ; Wilson ( 2013 .01 ) ; A61K 9 /2013 (2013 . 01 ) ; A61K Caparros - Wanderely , Buckinghamshire 31/ 192 ( 2013 .01 ) ; A61K 31 /60 ( 2013 .01 ) ; (GB ) ; Suzanne J . Dilly , Oxfordshire A61K 47 / 10 ( 2013 .01 ) ; A61K 47 /44 ( 2013 .01 ) ; (GB ) ; Olga Pleguezeulos Mateo , A61K 31 / 19 ( 2013 . 01 ) ; A61K 31 / 202 Bicester (GB ) ; Gregory A . Stoloff , (2013 .01 ) ; A61K 31/ 25 ( 2013 .01 ) ; AIK London (GB ) 31 / 337 ( 2013. 01 ) ; A6IK 31/ 704 ( 2013 .01 ) ( 73 ) Assignee : Infirst Healthcare Limited , London (58 ) Field of Classification Search (GB ) CPC . .. .. A61K 31 /192 ; A61K 31/ 19 USPC .. .. .. 514 / 570 , 571, 557 ( * ) Notice : Subject to any disclaimer, the term of this See application file for complete search history . patent is extended or adjusted under 35 U . S . C . 154 (b ) by 0 days . References Cited This patent is subject to a terminal dis (56 ) claimer . U . S . PATENT DOCUMENTS 3 , 228 ,831 A 1 / 1966 Nicholson et al. (21 ) Appl . No. : 15 / 614 ,592 3 , 800 ,038 A 3 / 1974 Rudel 4 ,571 ,400 A 2 / 1986 Arnold (22 ) Filed : Jun .
    [Show full text]
  • Lipid Glossary 2 Was Published by the Oily Press in 2004 and Is Available Free of Charge from the Publisher's Web Site
    This electronic version of Lipid Glossary 2 was published by The Oily Press in 2004 and is available free of charge from the publisher's web site. A printed and bound hardback copy of the book can also be purchased from the web site: www.pjbarnes.co.uk/op/lg2.htm LIPID GLOSSARY 2 Frank D. Gunstone Honorary Professor, Scottish Crop Research Institute, Dundee, UK Bengt G. Herslöf Managing Director, Scotia LipidTeknik AB, Stockholm, Sweden THE OILY PRESS BRIDGWATER ii Copyright © 2000 PJ Barnes & Associates PJ Barnes & Associates, PO Box 200, Bridgwater TA7 0YZ, England Tel: +44-1823-698973 Fax: +44-1823-698971 E-mail: [email protected] Web site: http://www.pjbarnes.co.uk All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted by any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission in writing from the publisher. All reasonable care is taken in the compilation of information for this book. However, the author and publisher do not accept any responsibility for any claim for damages, consequential loss or loss of profits arising from the use of the information. ISBN 0-9531949-2-2 This book is Volume 12 in The Oily Press Lipid Library Publisher's note: Lipid Glossary 2 is based on A Lipid Glossary, which was published by The Oily Press in 1992 (ISBN 0-9514171-2-6). However, Lipid Glossary 2 is more than simply a revised and updated edition of the earlier book — it is also much extended, with more than twice as many pages, and a much greater number of graphics (see Preface).
    [Show full text]
  • Stearic Acid
    STEARIC ACID www.pawarchemicals.com PRODUCT IDENTIFICATION CAS NO. 57-11-4 EINECS NO. 200-313-4 FORMULA CH3(CH2)16COOH MOL WT. 284.48 H.S. CODE 2915.70.0120 SMILES C(CCCCCCCCCCC)CCCCCC(=O)O TOXICITY SYNONYMS n-Octadecanoate; 1-Heptadecanecarboxylic acid; n-Octadecylic acid; Cetylacetic acid; Acide octadecylique; Acide stearique; Stearophanic acid; Octadecanoic acid; Other CAS RN: 8013-28-3, 8023-06-1, 8037-83-0, 8037-40-9, 8039-54-1, 8039-53-0, 8039-52-9, 8039-51-8, 39390-61-9, 58392-66-8, 82497-27-6, 134503-33-6, 197923-10-7, 294203-07-9 EXTRA NOTES EPA Pesticide Chemical Code 079082, FEMA No. 3035 CLASSIFICATION Fatty Acid PHYSICAL AND CHEMICAL PROPERTIES PHYSICAL STATE White to yellowish solid MELTING POINT 67 - 69 C BOILING POINT 361 SPECIFIC GRAVITY 0.94 SOLUBILITY IN WATER 0.1-1 g/100 ml at 23 C OH RATE 2.25E-11 (cm3/molecule-sec at 25 C Atmospheric ) VAPOR DENSITY 9.8 HENRY LAW CONSTANT 4.76E-07 (atm-m3/mole at 25 C) Constant Health: 1 Flammability: 1 Reactivity: 0 NFPA RATINGS REFRACTIVE INDEX FLASH POINT 196 C STABILITY Stable under ordinary conditions EXTERNAL LINKS &GENERAL DESCRIPTION Wikipedia Linking Material Safety Data Sheet Google Scholar Search GENERAL DESCRIPTION: Fatty Acids are aliphatic carboxylic acid with varying hydrocarbon lengths at one end of the chain joined to terminal carboxyl (-COOH) group at the other end. The general formula is R-(CH2)n-COOH. Fatty acids are predominantly unbranched and those with even numbers of carbon atoms between 12 and 22 carbons long react with glycerol to form lipids (fat-soluble components of living cells) in plants, animals, and microorganisms.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8.481,020 B2 Nouvel Et Al
    USOO8481020B2 (12) United States Patent (10) Patent No.: US 8.481,020 B2 Nouvel et al. (45) Date of Patent: Jul. 9, 2013 (54) PHEROMONE COMPOSITIONS AND (58) Field of Classification Search METHODS OF USE None See application file for complete search history. (75) Inventors: Larry Nouvel, Plano, TX (US); Luis Rios, Pembroke Pines, FL (US); Cuong (56) References Cited Tu Ba, Miami, FL (US) U.S. PATENT DOCUMENTS (73) Assignee: Sergeant's Pet Care Products, Inc., 6,077,867 A 6/2000 Pageat Omaha, NE (US) 6,169,113 B1 1/2001 Pageat 6,384.252 B1* 5/2002 Pageat ... 554.223 (*) Notice: Subject to any disclaimer, the term of this 2009/0275670 A1* 11/2009 Marshall . 514,772.3 patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days. OTHER PUBLICATIONS International Search Report and Opinion issued in PCT/US 10/61564 (21) Appl. No.: 12/974,565 dated Mar. 3, 2011. (22) Filed: Dec. 21, 2010 * cited by examiner Prior Publication Data (65) Primary Examiner — Neil Levy US 2011 FO150822 A1 Jun. 23, 2011 (74) Attorney, Agent, or Firm — Polsinelli PC Related U.S. Application Data (57) ABSTRACT (60) Provisional application No. 61/288,643, filed on Dec. 21, 2009. Pheromone compositions based on a combination of squalene, linoleic acid and 1-docosanol are described. The (51) Int. C. compositions are useful for behavior modification in mam AOIN 25/02 (2006.01) mals that exhibit undesirable or harmful stress-related behav (52) U.S. C. 1O.S. USPC ............. 424/84; 424/405; 424/406; 514/560; 514/724:514/760 8 Claims, 2 Drawing Sheets Behavior improvement Feliway diffuser Cat Collar Feliway diffuser Cat Collar U.S.
    [Show full text]
  • For Analyst. This Journal Is © the Royal Society of Chemistry 2018
    Electronic Supplementary Material (ESI) for Analyst. This journal is © The Royal Society of Chemistry 2018 Electronic Supplementary Information (ESI) Multiple Reaction Monitoring (MRM)-Profiling with Biomarker Identification by LC-QTOF to Characterize Coronary Artery Disease Karen E. Yannell1, Christina R. Ferreira1, Shane Tichy2, R. Graham Cooks1 1 Chemistry Department, Purdue University, West Lafayette, IN 47907, US 2Agilent Technologies, Santa Clara, CA 95051, US Table of Contents 1. EXPERIMENTAL SYSTEM ...............................................................................................................................1 1.1 INSTRUMENT CONFIGURATION AND SAMPLE INTRODUCTION .....................................................................................1 1.2 SAMPLE PREPARATION.......................................................................................................................................2 2. METHOD DEVELOPMENT..............................................................................................................................3 2.1 SOLVENT EVALUATION .......................................................................................................................................3 2.2 ION SOURCE CONDITIONS...................................................................................................................................4 2.3 DATA FOR DIFFERENT SOLVENTS AND COLLISION ENERGIES .......................................................................................4 2.4 PRECURSOR
    [Show full text]
  • Fatty Acids and Related Masses
    Fatty Acids and Related Masses For HRAM MS, Masses of ions now include loss or gain of a mole of electrons per mole of ions for = -/+ 0.00054486 g/mol Fatty Acid Pure Pure Pure Pure + + + + – Systematic Fatty Acid Name Common Fatty Acid Name Abbrev. Fatty Acid Mass Methyl Ester [RCOO+58] [RCOO+58-H2O] [RCO] [RCO-H2O] [RCOO] Triglyceride Triglyceride Diglyceride Diglyceride + + CUECN =[RCO+74] =[RCO+74-H2O] (– mode) Nominal Nominal Butanoic acid Butyric acid Bu 4 : 0 4 88.0524 102.0681 145.0859 127.0748 71.0491 53.0380 87.0452 302.1729 302 215.1283 215 Pentanoic acid Valeric acid V 5 : 0 5 102.0681 116.0837 159.1021 141.0916 85.0653 67.0548 101.0603 344.2199 344 243.1596 243 Hexanoic acid Caproic acid Co 6 : 0 6 116.0837 130.0994 173.1178 155.1072 99.0810 81.0704 115.0759 386.2668 386 271.1909 271 Heptanoic acid Enanthic acid En 7 : 0 7 130.0994 144.1150 187.1334 169.1229 113.0966 95.0861 129.0916 428.3138 428 299.2222 299 Octanoic acid Caprylic acid Cy 8 : 0 8 144.1150 158.1307 201.1491 183.1385 127.1123 109.1017 143.1072 470.3607 470 327.2535 327 Nonanoic acid Pelargonic acid 9 : 0 9 158.1307 172.1463 215.1647 197.1542 141.1279 123.1174 157.1229 512.4077 512 355.2848 355 Decanoic acid Capric acid Ca 10 : 0 10 172.1463 186.1620 229.1804 211.1698 155.1436 137.1330 171.1385 554.4546 554 383.3161 383 Hendecanoic acid Undecylic acid 11 : 0 11 186.1620 200.1776 243.1960 225.1855 169.1592 151.1487 185.1542 596.5016 596 411.3474 411 Dodecanoic acid Lauric acid La 12 : 0 12 200.1776 214.1933 257.2117 239.2011 183.1749 165.1643 199.1698 638.5485
    [Show full text]
  • Tepzz 7777 Za T
    (19) TZZ Z_T (11) EP 2 777 720 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 17.09.2014 Bulletin 2014/38 A61L 24/04 (2006.01) A61L 24/00 (2006.01) (21) Application number: 14159968.8 (22) Date of filing: 14.03.2014 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • TROXEL, Karen S. GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO Warsaw, IN Indiana 46580 (US) PL PT RO RS SE SI SK SM TR • PONTICIELLO, Michael Designated Extension States: Mission Viejo, CA California 92691 (US) BA ME (74) Representative: Morawski, Birgit (30) Priority: 15.03.2013 US 201361800317 P Maikowski & Ninnemann Patentanwälte (71) Applicant: Biomet Manufacturing, LLC Postfach 15 09 20 Warsaw, IN 46582 (US) 10671 Berlin (DE) (54) Hemostatic compositions and methods (57) Compositions and methods for achieving he- an anti-infective agent. The hemostatic composition can mostasis. Hemostatic compositions comprise a phos- be administered to a bleeding bone to achieve hemos- pholipid, particularly phosphatidylcholine, and optionally, tasis. EP 2 777 720 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 777 720 A1 Description CROSS-REFERENCE TO RELATED APPLICATIONS 5 [0001] This application claims the benefit of U.S. Provisional Application No. 61/800,317, filed on March 15, 2013. The entire disclosure of the above application is incorporated herein by reference. INTRODUCTION 10 [0002] Bone is highly vascularized and, when cut, can bleed profusely. Bleeding can be difficult to control during orthopedic surgeries, particularly involving the spine and sternum.
    [Show full text]